This evidence supports a model where NKX2-5 mutations contribute to DCM pathogenesis through altered gene regulation and impaired transcriptional networks, highlighting their significant impact on cardiac structural and functional integrity [191,192]. Here, NKX2-5 is linked to familial dilated cardiomyopathy.